肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ASH指南：新诊断老年急性髓性白血病的治疗

2020-08-09 美国血液病学会 Blood Adv . 2020 Aug 11;4(15):3528-3549.

急性髓性白血病

2020年8月，美国血液病学会(ASH)发布了新诊断老年急性髓性白血病的治疗指南，老年急性髓性白血病患者基于疾病和临床危险因素，患者目标，预后以及医生和患者感知的治疗风险和益处影响其治疗建议。本文主要

中文标题：

2020 ASH指南：新诊断老年急性髓性白血病的治疗

英文标题：

American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

发布机构：

美国血液病学会

发布日期：

2020-08-09

简要介绍：

2020年8月，美国血液病学会(ASH)发布了新诊断老年急性髓性白血病的治疗指南，老年急性髓性白血病患者基于疾病和临床危险因素，患者目标，预后以及医生和患者感知的治疗风险和益处影响其治疗建议。本文主要针对新诊断老年急性髓性白血病的治疗提供指导建议，最终针对6个临床问题达成一致建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ASH指南：新诊断老年急性髓性白血病的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c13901c00195354e, title=2020 ASH指南：新诊断老年急性髓性白血病的治疗, enTitle=American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults, guiderFrom=Blood Adv . 2020 Aug 11;4(15):3528-3549., authorId=0, author=, summary=2020年8月，美国血液病学会(ASH)发布了新诊断老年急性髓性白血病的治疗指南，老年急性髓性白血病患者基于疾病和临床危险因素，患者目标，预后以及医生和患者感知的治疗风险和益处影响其治疗建议。本文主要, cover=https://img.medsci.cn/2020817/1597677276984_2020535.jpg, journalId=0, articlesId=null, associationId=25, associationName=美国血液病学会, associationIntro=美国血液病学会---是全球最大的关于血液疾病病因及治疗的专业协会。其使命为通过促进血液学的研究、临床护理、教育、培训及宣传而进一步促进对血液、骨髓、免疫、凝血及脉管系统疾病的了解、诊断与防治。ASH的官方杂志为《血液》，是该领域被引用最多的同行评议杂志，周刊。, copyright=0, guiderPublishedTime=Sun Aug 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，美国血液病学会(ASH)发布了新诊断老年急性髓性白血病的治疗指南，老年急性髓性白血病患者基于疾病和临床危险因素，患者目标，预后以及医生和患者感知的治疗风险和益处影响其治疗建议。本文主要针对新诊断老年急性髓性白血病的治疗提供指导建议，最终针对6个临床问题达成一致建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=743, tagName=急性髓性白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=743, guiderKeyword=急性髓性白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6611, appHits=284, showAppHits=0, pcHits=1038, showPcHits=6327, likes=1, shares=14, comments=13, approvalStatus=1, publishedTime=Mon Aug 17 23:41:12 CST 2020, publishedTimeString=2020-08-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 17 23:14:43 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:26:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ASH指南：新诊断老年急性髓性白血病的治疗.pdf)])
2020 ASH指南：新诊断老年急性髓性白血病的治疗.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066186, encodeId=54c91066186c9, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056556, encodeId=1e8e105655632, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:34:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016872, encodeId=696110168e2b3, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49632726260, createdName=jjhome1988, createdTime=Sun Sep 12 22:14:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995900, encodeId=b132995900fd, content=好好学习，有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9Tk4XOZgvERlYicyGYfx0vhVvabicdbFjEupwv7ZFgIA8Cia0w1ETblx1ow6QaHWuDK0jrlicqV4aSg/132, createdBy=29752552677, createdName=李娜医生, createdTime=Sat Jul 03 21:41:33 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966165, encodeId=6b609661658b, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad95502127, createdName=ms2000000148848130, createdTime=Mon May 17 07:43:57 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-11-02 denglimoxiaoran

    #学习#学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066186, encodeId=54c91066186c9, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056556, encodeId=1e8e105655632, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:34:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016872, encodeId=696110168e2b3, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49632726260, createdName=jjhome1988, createdTime=Sun Sep 12 22:14:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995900, encodeId=b132995900fd, content=好好学习，有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9Tk4XOZgvERlYicyGYfx0vhVvabicdbFjEupwv7ZFgIA8Cia0w1ETblx1ow6QaHWuDK0jrlicqV4aSg/132, createdBy=29752552677, createdName=李娜医生, createdTime=Sat Jul 03 21:41:33 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966165, encodeId=6b609661658b, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad95502127, createdName=ms2000000148848130, createdTime=Mon May 17 07:43:57 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-09-30 13f0c37dm61暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066186, encodeId=54c91066186c9, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056556, encodeId=1e8e105655632, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:34:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016872, encodeId=696110168e2b3, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49632726260, createdName=jjhome1988, createdTime=Sun Sep 12 22:14:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995900, encodeId=b132995900fd, content=好好学习，有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9Tk4XOZgvERlYicyGYfx0vhVvabicdbFjEupwv7ZFgIA8Cia0w1ETblx1ow6QaHWuDK0jrlicqV4aSg/132, createdBy=29752552677, createdName=李娜医生, createdTime=Sat Jul 03 21:41:33 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966165, encodeId=6b609661658b, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad95502127, createdName=ms2000000148848130, createdTime=Mon May 17 07:43:57 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-09-12 jjhome1988

    有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1066186, encodeId=54c91066186c9, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056556, encodeId=1e8e105655632, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:34:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016872, encodeId=696110168e2b3, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49632726260, createdName=jjhome1988, createdTime=Sun Sep 12 22:14:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995900, encodeId=b132995900fd, content=好好学习，有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9Tk4XOZgvERlYicyGYfx0vhVvabicdbFjEupwv7ZFgIA8Cia0w1ETblx1ow6QaHWuDK0jrlicqV4aSg/132, createdBy=29752552677, createdName=李娜医生, createdTime=Sat Jul 03 21:41:33 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966165, encodeId=6b609661658b, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad95502127, createdName=ms2000000148848130, createdTime=Mon May 17 07:43:57 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-07-03 李娜医生

    好好学习，有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1066186, encodeId=54c91066186c9, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Tue Nov 02 12:08:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056556, encodeId=1e8e105655632, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:34:49 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016872, encodeId=696110168e2b3, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49632726260, createdName=jjhome1988, createdTime=Sun Sep 12 22:14:54 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995900, encodeId=b132995900fd, content=好好学习，有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq9Tk4XOZgvERlYicyGYfx0vhVvabicdbFjEupwv7ZFgIA8Cia0w1ETblx1ow6QaHWuDK0jrlicqV4aSg/132, createdBy=29752552677, createdName=李娜医生, createdTime=Sat Jul 03 21:41:33 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966165, encodeId=6b609661658b, content=非常感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad95502127, createdName=ms2000000148848130, createdTime=Mon May 17 07:43:57 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-05-17 ms2000000148848130

    非常感谢

    0

相关指南

2015 BCSH指南：妊娠期急性髓性白血病的诊断和管理

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2015-06-17

拓展阅读

2015 BCSH指南：妊娠期急性髓性白血病的诊断和管理

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2015-06-17

2021 ELN共识文件：急性髓性白血病的可测量残留病（更新版）

欧洲白血病网(ELN,European LeukmiaNet) · 2021-11-01

FDA 行业指南：急性髓性白血病的开发治疗药物和生物制品

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2022-10-17

2023 SIOG建议：70岁及以上急性髓性白血病患者的治疗

国际老年肿瘤学会(SIOG,International Society of Geriatric Oncology) · 2023-09-21

2023 GFCH指南：细胞遗传学在急性髓性白血病和组织细胞/树突状细胞肿瘤管理中的应用

暂未更新 · 2023-12-29

2023 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-1.急性髓性白血病

暂未更新 · 2024-03-14